Rapid Influenza Diagnostic Tests Market, By Type (Influenza A and Influenza B), By Product Type, By End Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
REPORT HIGHLIGHT
Rapid Influenza Diagnostic Tests Market size was valued at USD 1,396.78 Million in 2024, expanding to a CAGR of 5.2% from 2025 to 2032.
Rapid Influenza Diagnostic Tests (RIDTs) are fast diagnostic tools used to detect influenza viruses in respiratory samples. Typically delivering results in 10-15 minutes, these tests are commonly employed in clinics, hospitals, and doctor\'s offices to quickly diagnose flu infections.
Rapid Influenza Diagnostic Tests Market- Market Dynamics
Ø Rising Prevalence of Influenza and Respiratory Diseases, and Growing Demand for POC Testing to Drive Market Growth
The rapid growth of the rapid influenza diagnostic tests (RIDTs) market is largely driven by the rising frequency of seasonal influenza outbreaks globally. According to the World Health Organization (WHO), influenza infects millions of individuals each year, leading to severe complications, hospitalizations, and fatalities, especially among vulnerable populations such as children, the elderly, and individuals with underlying health conditions. In light of the COVID-19 pandemic, concerns over respiratory illnesses have intensified, creating a heightened demand for rapid diagnostic tests that can distinguish influenza from other viral diseases. Initiatives by organizations like the Centers for Disease Control and Prevention (CDC) and the WHO, which emphasize timely flu testing and vaccination, have further fueled the demand for RIDTs. Furthermore, efforts to improve healthcare access and expand universal healthcare coverage, particularly in low-income countries, are contributing to the increasing adoption of RIDTs in these regions.
The shift toward point-of-care (POC) testing plays a pivotal role in the growing demand for RIDTs. Healthcare providers and patients are increasingly opting for fast, accessible, and affordable diagnostic solutions. RIDTs offer immediate results in 10–15 minutes, making them ideal for use in settings such as clinics, pharmacies, emergency rooms, and remote healthcare facilities. The rise of self-testing kits is also driving growth, providing individuals with the convenience of testing at home. Compared to the more expensive and time-consuming polymerase chain reaction (PCR) tests, RIDTs are quicker, simpler, and more cost-effective, making them an attractive option for mass screening campaigns and routine diagnostic use. These benefits are especially impactful in low-resource areas, where access to laboratory-based testing is limited, enabling widespread and efficient influenza detection.
Rapid Influenza Diagnostic Tests Market- Segmentation Analysis:
The Global Rapid Influenza Diagnostic Tests Market is segmented based on Type, Product Type, End Use, and Region.
The market is categorized into two segments based on type: influenza A and influenza B. The influenza A segment holds the dominant market share. This is due to the higher incidence of influenza A infections globally, along with the increasing need for rapid diagnostic solutions to manage outbreaks and minimize the spread. According to the U.S. Centers for Disease Control and Prevention (CDC), influenza A is responsible for the majority of seasonal flu cases in the United States, which drives the demand for efficient diagnostic tools that can detect the virus early and ensure timely treatment.
The market is further segmented based on product type into digital diagnostic tests and conventional diagnostic tests. The digital diagnostic tests segment is expected to capture the largest share due to the growing adoption of advanced digital platforms in hospitals and healthcare facilities for rapid influenza testing. Digital diagnostic tools, which include PCR tests and automated antigen detection systems, offer faster results and higher accuracy compared to traditional methods. The CDC reports that digital and molecular testing methods are increasingly favored due to their efficiency in detecting viral pathogens like influenza, supporting the market\'s shift toward digital solutions.
Based on end-use, the market is divided into hospitals, diagnostic centers, and research institutions. The hospitals segment holds the largest share of the end-use market, driven by the rising number of hospital admissions for respiratory illnesses and the increasing need for specialized care. Hospitals are major consumers of diagnostic equipment as they cater to large volumes of patients requiring rapid and accurate influenza diagnoses, especially during peak flu seasons. According to the World Health Organization (WHO), the global burden of respiratory diseases continues to rise, further driving the need for efficient influenza diagnostic tests in healthcare settings.
Rapid Influenza Diagnostic Tests Market- Geographical Insights
The global Rapid Influenza Diagnostic Tests (RIDTs) market spans across regions such as North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America leads the market, largely driven by government initiatives and substantial investments in healthcare infrastructure. The United States, in particular, benefits from robust healthcare systems and national influenza control programs, supported by agencies like the Centers for Disease Control and Prevention (CDC). Government programs focused on timely flu diagnosis, as well as an emphasis on flu vaccination, continue to drive demand for rapid diagnostic solutions in the region. According to the CDC, influenza is responsible for significant morbidity and mortality each year in the U.S., further emphasizing the need for rapid testing solutions.
In the Asia Pacific region, the RIDTs market is witnessing rapid expansion due to increasing healthcare expenditures, growing public awareness about the importance of early diagnosis and treatment, and the rising burden of influenza. Countries like China, India, and Japan are leading this growth as healthcare access improves and more people seek timely diagnostics for influenza infections. However, despite this growth potential, challenges such as limited access to advanced diagnostic tools in rural or economically constrained areas may slow the rate of market expansion. Nevertheless, initiatives from governments to improve healthcare access and diagnostics, particularly in rural or underserved areas, are helping to overcome these barriers and boost the market\'s growth.
Rapid Influenza Diagnostic Tests Market- Competitive Landscape:
The Rapid Influenza Diagnostic Tests (RIDTs) market is witnessing significant competition among key players, with growth driven by technological innovations, strategic initiatives, and the increasing demand for quick and accurate influenza diagnostics. The introduction of combination tests that can detect multiple pathogens, including both influenza and COVID-19, is gaining popularity. These multiplex tests are enhancing diagnostic efficiency, improving patient management, and supporting healthcare systems in responding to respiratory outbreaks more effectively.
Recent Developments:
v In May 2023, MaximBio secured a contract with the National Institutes of Health (NIH) to develop a new rapid test platform aimed at advancing diagnostic capabilities.
v In 2024, Siemens AG launched a new medical diagnostic solution for influenza testing, expanding its portfolio and strengthening its presence in the diagnostic market.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL RAPID INFLUENZA DIAGNOSTIC TESTS MARKET KEY PLAYERS
Ø Abbott Laboratories
Ø Becton, Dickinson and Company
Ø MaximBio
Ø bioMérieux SA
Ø Bio-Rad Laboratories Inc.
Ø Danaher Corporation
Ø F. Hoffmann-La Roche Ltd
Ø Hologic, Inc.
Ø Luminex Corporation
Ø Meridian Bioscience
Ø Quidel Corporation
Ø Siemens Healthineers AG
Ø Thermo Fisher Scientific Inc.
Ø Sekisui Diagnostics
Ø GenMark Diagnostics
Ø Alere Inc.
Ø Others
GLOBAL RAPID INFLUENZA DIAGNOSTIC TESTS MARKET, BY TYPE- MARKET ANALYSIS, 2019-2032
Ø Influenza A
Ø Influenza B
GLOBAL RAPID INFLUENZA DIAGNOSTIC TESTS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019-2032
Ø Digital Diagnostic Tests
Ø Conventional Diagnostic Tests
GLOBAL RAPID INFLUENZA DIAGNOSTIC TESTS MARKET, BY END USE- MARKET ANALYSIS, 2019-2032
Ø Hospitals
Ø Diagnostic Centers
Ø Research
GLOBAL RAPID INFLUENZA DIAGNOSTIC TESTS MARKET, BY REGION- MARKET ANALYSIS, 2019-2032
Ø North America
o The U.S.
o Canada
Ø Europe
o Germany
o France
o Italy
o Spain
o United Kingdom
o Russia
o Netherlands
o Sweden
o Poland
o Rest of Europe
Ø Asia Pacific
o India
o China
o South Korea
o Japan
o Australia
o Thailand
o Indonesia
o Philippines
o Rest of APAC
Ø Latin America
o Brazil
o Mexico
o Argentina
o Colombia
o Rest of LATAM
Ø The Middle East and Africa
o Saudi Arabia
o UAE
o Israel
o Turkey
o Algeria
o Egypt
o Rest of MEA
TABLE OF CONTENT
1. Rapid Influenza Diagnostic Tests Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Rapid Influenza Diagnostic Tests Market Snippet by Type
2.1.2. Rapid Influenza Diagnostic Tests Market Snippet by Product Type
2.1.3. Rapid Influenza Diagnostic Tests Market Snippet by End Use
2.1.4. Rapid Influenza Diagnostic Tests Market Snippet by Country
2.1.5. Rapid Influenza Diagnostic Tests Market Snippet by Region
2.2. Competitive Insights
3. Rapid Influenza Diagnostic Tests Key Market Trends
3.1. Rapid Influenza Diagnostic Tests Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Rapid Influenza Diagnostic Tests Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Rapid Influenza Diagnostic Tests Market Opportunities
3.4. Rapid Influenza Diagnostic Tests Market Future Trends
4. Rapid Influenza Diagnostic Tests Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Rapid Influenza Diagnostic Tests Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Rapid Influenza Diagnostic Tests Market Landscape
6.1. Rapid Influenza Diagnostic Tests Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Rapid Influenza Diagnostic Tests Market – By Type
7.1. Overview
7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
7.1.2. Influenza A
7.1.3. Influenza B
8. Rapid Influenza Diagnostic Tests Market – By Product Type
8.1. Overview
8.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
8.1.2. Digital Diagnostic Tests
8.1.3. Conventional Diagnostic Tests
9. Rapid Influenza Diagnostic Tests Market – By End Use
9.1. Overview
9.1.1. Segment Share Analysis, By End Use, 2024 & 2032 (%)
9.1.2. Hospitals
9.1.3. Diagnostic Centers
9.1.4. Research
10. Rapid Influenza Diagnostic Tests Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Rapid Influenza Diagnostic Tests Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Rapid Influenza Diagnostic Tests Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.8. UK
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.8.4. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.8.5. UK Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.9. France
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.9.4. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.9.5. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.10. Italy
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.10.4. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.10.5. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.11. Spain
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.3. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.11.4. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.11.5. Spain Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.12. The Netherlands
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.3. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.12.4. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.12.5. The Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.13. Sweden
10.3.13.1. Overview
10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.13.5. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.14. Russia
10.3.14.1. Overview
10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.14.4. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.14.5. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.15. Poland
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.15.5. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.16. Rest of Europe
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.16.4. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.16.5. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Rapid Influenza Diagnostic Tests Key Manufacturers in Asia Pacific
10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.5. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.6. APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.7. China
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.7.4. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.7.5. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.8.4. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.8.5. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.12. Indonesia
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.12.4. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.12.5. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.13. Thailand
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.13.4. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.13.5. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.5. Latin America (LATAM)
10.5.1. Overview
10.5.2. Rapid Influenza Diagnostic Tests Key Manufacturers in Latin America
10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.5. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.6. LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa (MEA)
10.6.1. Overview
10.6.2. Rapid Influenza Diagnostic Tests Key Manufacturers in Middle East and Africa
10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.5. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.6. MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.8. UAE
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. UAE Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.8.4. UAE Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.8.5. UAE Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Rapid Influenza Diagnostic Tests Industry
11.1. Competitive Dashboard
11.1.1. Competitive Benchmarking
11.1.2. Competitive Positioning
11.2. Company Profiles
11.2.1. Abbott Laboratories
11.2.2. Becton, Dickinson and Company
11.2.3. MaximBio
11.2.4. bioMérieux SA
11.2.5. Bio-Rad Laboratories Inc.
11.2.6. Danaher Corporation
11.2.7. F. Hoffmann-La Roche Ltd
11.2.8. Hologic, Inc.
11.2.9. Luminex Corporation
11.2.10. Meridian Bioscience
11.2.11. Quidel Corporation
11.2.12. Siemens Healthineers AG
11.2.13. Thermo Fisher Scientific Inc.
11.2.14. Sekisui Diagnostics
11.2.15. GenMark Diagnostics
11.2.16. Alere Inc.
11.2.17. Others
12. 360 Degree AnalystView
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
